Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-26 @ 12:57 AM
NCT ID: NCT02470234
Description: Definitions for SAEs and AEs do not differ from ClinicalTrials.gov definitions
Frequency Threshold: 0
Time Frame: From check in until 24 hours post dose
Study: NCT02470234
Study Brief: Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Methylphenidate HCl ER 10 mg Subjects received a single dose of Methylphenidate HCl ER 10 mg 0 None 0 5 1 5 View
Methylphenidate HCl ER 15 mg Subjects received a single dose of Methylphenidate HCl ER 15 mg 0 None 0 3 0 3 View
Methylphenidate HCl ER 20 mg Subjects received a single dose of Methylphenidate HCl ER 20 mg 0 None 0 2 0 2 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations None View